p38 mitogen-activated protein kinase and pain.
Inflammatory and neuropathic pain is initiated by tissue inflammation and nerve injury, respectively. Both are characterized by increased activity in the peripheral and central nervous system, where multiple inflammatory cytokines and other active molecules activate different signaling pathways that involve in the development and/or maintenance of pain. P38 mitogen-activated protein kinase (MAPK) is one member of the MAPK family, which is activated in neurons and glia and contributes importantly to inflammatory and neuropathic pain. The aim of this review is to summarize the latest advances made about the implication of p38 MAPK signaling cascade in pain. It can deepen our understanding of the molecular mechanisms of pain and may help to offer new targets for pain treatment.
['Mai|Lijia|L|', 'Zhu|Xiao|X|', 'Huang|Fang|F|', 'He|Hongwen|H|', 'Fan|Wenguo|W|']
D000818:Animals D002986:Clinical Trials as Topic D004789:Enzyme Activation D006801:Humans D010146:Pain D048051:p38 Mitogen-Activated Protein Kinases
Pain Glial cells p38 MAP kinase